X

Vous n'êtes pas connecté

Maroc Maroc - KNOWRIDGE.COM - A La Une - 24/Nov 00:17

New drug may help prevent spread of deadly skin cancer

A major new clinical study has found that a type of immunotherapy may help stop a rare and fast-growing skin cancer from spreading to other parts of the body. The drug, pembrolizumab (brand name KEYTRUDA), was tested in patients with Merkel cell carcinoma, a rare but aggressive form of skin cancer. The trial, called STAMP […] The post New drug may help prevent spread of deadly skin cancer appeared first on Knowridge Science Report.

Articles similaires

New drug may help prevent spread of deadly skin cancer

knowridge.com - 24/Nov 00:17

A major new clinical study has found that a type of immunotherapy may help stop a rare and fast-growing skin cancer from spreading to other parts of...

Early immunotherapy shows higher response in advanced basal cell carcinoma

news.medical.net - 18/Nov 19:18

A new study led by researchers at the Johns Hopkins Kimmel Cancer Center found that patients with advanced basal cell carcinoma (BCC) may benefit from...

COVID mRNA vaccines may help cancer patients live longer

knowridge.com - 23/Nov 15:04

A new study brings exciting news for people with advanced lung or skin cancer. Researchers found that patients who received a COVID-19 mRNA vaccine...

COVID mRNA vaccines may help cancer patients live longer

knowridge.com - 23/Nov 15:04

A new study brings exciting news for people with advanced lung or skin cancer. Researchers found that patients who received a COVID-19 mRNA vaccine...

Sorry! Image not available at this time

FDA Approves Keytruda (pembrolizumab) and Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev (enfortumab vedotin-ejfv), as Perioperative Treatment for Adults with Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

drugs.com - 21/Nov 22:11

RAHWAY, N.J.--(BUSINESS WIRE) November 21, 2025 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the...

Missing cancer gene may boost response to immunotherapy

news.medical.net - 02:17

For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope.

Missing cancer gene may boost response to immunotherapy

news.medical.net - 02:17

For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope.

A new drug may stop nerve damage in cancer treatment

knowridge.com - 22/Nov 15:30

Many people going through chemotherapy experience pain, tingling, or numbness in their hands and feet. This condition is called chemotherapy-induced...

A new drug may stop nerve damage in cancer treatment

knowridge.com - 22/Nov 15:30

Many people going through chemotherapy experience pain, tingling, or numbness in their hands and feet. This condition is called chemotherapy-induced...

New drug combo cuts 40% death risk in aggressive prostate cancer

knowridge.com - 23/Nov 15:06

A powerful new treatment could soon help men whose prostate cancer returns after surgery or radiation. A large study shows that combining a drug...